JP2017513876A - Cosmetic composition containing mint vinegar as an active ingredient - Google Patents
Cosmetic composition containing mint vinegar as an active ingredient Download PDFInfo
- Publication number
- JP2017513876A JP2017513876A JP2016563931A JP2016563931A JP2017513876A JP 2017513876 A JP2017513876 A JP 2017513876A JP 2016563931 A JP2016563931 A JP 2016563931A JP 2016563931 A JP2016563931 A JP 2016563931A JP 2017513876 A JP2017513876 A JP 2017513876A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- mint
- cosmetic composition
- dosage form
- vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000006679 Mentha X verticillata Nutrition 0.000 title claims abstract description 50
- 235000002899 Mentha suaveolens Nutrition 0.000 title claims abstract description 50
- 235000001636 Mentha x rotundifolia Nutrition 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 239000002537 cosmetic Substances 0.000 title claims abstract description 33
- 239000000052 vinegar Substances 0.000 title claims abstract description 25
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 25
- 239000004480 active ingredient Substances 0.000 title claims abstract description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 57
- 239000011148 porous material Substances 0.000 claims description 38
- 210000002374 sebum Anatomy 0.000 claims description 21
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 229940105902 mint extract Drugs 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 5
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 4
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 4
- 244000283763 Acetobacter aceti Species 0.000 claims description 2
- 235000007847 Acetobacter aceti Nutrition 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 description 55
- 239000002552 dosage form Substances 0.000 description 35
- 238000012360 testing method Methods 0.000 description 35
- 230000000052 comparative effect Effects 0.000 description 26
- 230000000694 effects Effects 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- -1 pinene Chemical compound 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000036559 skin health Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NOOLISFMXDJSKH-LPEHRKFASA-N Isomenthol Natural products CC(C)[C@@H]1CC[C@H](C)C[C@H]1O NOOLISFMXDJSKH-LPEHRKFASA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical group 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002517 constrictor effect Effects 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009962 secretion pathway Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本発明は、有効成分としてミントビネガーを含有する化粧料組成物に関する。【選択図】図2The present invention relates to a cosmetic composition containing mint vinegar as an active ingredient. [Selection] Figure 2
Description
本発明は、有効成分として、ミントビネガーを含有する化粧料組成物に関するものである。 The present invention relates to a cosmetic composition containing mint vinegar as an active ingredient.
本出願は、2014年4月24日に韓国特許庁に提出された韓国特許出願第10−2014−0049216号の出願日の利益を主張し、その全文は本明細書に参考として含まれる。 This application claims the benefit of the filing date of Korean Patent Application No. 10-2014-0049216 filed with the Korean Patent Office on April 24, 2014, the entire text of which is included herein by reference.
毛穴は、毛が育つ入口であり、汗孔とは異なり、直径は0.02〜0.05mm程度で、顔だけで約2万個あると知られている。この毛穴を介して皮脂が皮膚表面に流れ出る。思春期になれば、ホルモンが多く分泌され、皮脂腺が大きくなり、皮脂が多く分泌されるため、皮脂の分泌経路の毛穴が大きくなる。また、妊娠中や、ストレスを受けたとき、そして、天気が暖かいときにも皮脂の分泌が盛んになり、毛穴が大きくなる。 A pore is an entrance where hair grows, and unlike a sweat hole, the diameter is about 0.02 to 0.05 mm, and it is known that there are about 20,000 on the face alone. Sebum flows out to the skin surface through the pores. At puberty, many hormones are secreted, the sebaceous glands become larger, and more sebum is secreted, resulting in larger pores in the sebum secretion pathway. Also, during pregnancy, when stressed, and when the weather is warm, sebum secretion increases and pores become larger.
20代後半になると、皮膚の老化が始まり、毛穴の壁を支持していたコラーゲン、エラスチンなどが分解されるか又は変質されるので、皮膚の弾力性が低下し、毛穴が垂れるか又は広がる。毛穴が大きくなると、老廃物と細菌がよく浸透するようになり、にきびなどの様々な皮膚病が引き起こされる。 In the late twenties, aging of the skin begins, and collagen, elastin, etc. that supported the pore walls are decomposed or altered, so that the elasticity of the skin is lowered and the pores droop or spread. As pores grow larger, waste products and bacteria become more permeated, causing various skin diseases such as acne.
化粧品原料は、ほとんどの効能が不十分であるか、皮膚刺激のような副作用を誘発するなど、様々な問題点を有していた。そこで、皮膚の副作用を誘発することなく、皮膚再生増進効果を有する原料に対する研究が活発に進められている。特に、最近では、微生物を利用した発酵技術が発展し、植物やその他の天然原料に由来される物質を、発酵技術を介して得られた2次代謝産物を生理活性物質として利用する場合が多く増えている。この成分は、様々な生理活性を有することが知られており、高機能性化粧品の新原料として注目を集めている。この技術を利用すれば、天然に存在する物質であるが、その量が非常に少ないか、又は皮膚に適用することが困難であった高機能性活性物質を経済的に生産することができるという点で、これまで使用していなかった新成分を開発して応用することができるようになると期待されている。特に、機能性化粧品に対する顧客の要求が増大しているが、新機能性素材や関連技術の発展が十分でないという点で、無数に多くの新機能性成分を作り出すことができる発酵技術を利用した化粧品は、様々な皮膚効能、特に、抗老化効能の分野で大きな人気を集めるだろう。 Cosmetic raw materials have various problems, such as most of the effects are insufficient or side effects such as skin irritation are induced. Therefore, research on raw materials having an effect of promoting skin regeneration without inducing side effects on the skin has been actively conducted. In particular, recently, fermentation technology using microorganisms has been developed, and in many cases, substances derived from plants and other natural raw materials are used as physiologically active substances, secondary metabolites obtained through fermentation technology. is increasing. This component is known to have various physiological activities, and has attracted attention as a new raw material for highly functional cosmetics. By using this technology, it is possible to economically produce a highly functional active substance that is a naturally occurring substance, but whose amount is very small or difficult to apply to the skin. In this respect, it is expected that new components that have not been used so far can be developed and applied. In particular, although customers' demand for functional cosmetics is increasing, the use of fermentation technology that can produce innumerable new functional ingredients in that new functional materials and related technologies are not sufficiently developed. Cosmetics will gain great popularity in the field of various skin benefits, especially anti-aging benefits.
皮膚活性化と皮膚健康に役立つミントの効能を最大化して、老廃物を除去するだけでなく、毛穴の管理も可能にする化粧料組成物を提供する。 Provided is a cosmetic composition that maximizes the effectiveness of mint, which is useful for skin activation and skin health, not only to remove waste products, but also to manage pores.
そこで、本発明者はミントの効能を最大化させるために、ミントを酢酸発酵して化粧料組成物に使う場合、皮膚の毛穴と皮脂清浄効果を見出し、本発明の完成に至った。 Therefore, in order to maximize the efficacy of mint, the present inventor found skin pores and a sebum cleansing effect when mint was used in a cosmetic composition by fermentation with acetic acid, and the present invention was completed.
前記した目的を達成するために、本発明は、ミントビネガーを含有する化粧料組成物を提供する。 In order to achieve the above-described object, the present invention provides a cosmetic composition containing mint vinegar.
本発明に係る化粧物組成物は、効果的な有機酸菌の一つである酢酸菌とミントを発酵して得られたミントビネガーを含有しているので、血液浄化、抗菌、老化防止、新陳代謝を促進する効果を有しているだけでなく、代謝老廃物を除去し、毛穴を管理することが可能になる。 Since the cosmetic composition according to the present invention contains mint vinegar obtained by fermenting acetic acid bacteria and mint, which are effective organic acid bacteria, blood purification, antibacterial, anti-aging, metabolism In addition to having an effect of promoting aging, it is possible to remove metabolic waste products and manage pores.
また、優れた収斂作用があるため、毛穴が大きくなっているか又は弾力性が低下した皮膚に良く、掻痒感と炎症、にきびにも効果的な成分であるミントを酢酸発酵して、毛穴が広くなることを予防し、垂れた毛穴の弾力性を復活させる収縮効果があり、消毒及び鎮静効果がある。 Also, because of its excellent astringent action, it is good for skin with large pores or reduced elasticity, and mint, which is an effective ingredient for pruritus, inflammation and acne, is fermented with acetic acid to widen pores. It has a contraction effect that regains the elasticity of dripping pores, and has a disinfection and sedative effect.
ミント(学名:Mentha piperita)は、シソ科の多年生草木であり、東洋と西洋とを問わず、長い間、食用と薬用に使われてきた。多様な薬理作用に劣らず、皮膚健康に役立つ多様な効果があると知られている。ミントの主成分中の精油の含量は2%〜3%、花びらで4%〜6%、茎で0.3%と高い精油含量を示した。このようなミント精油の主成分の70%〜90%は、メントールであり、I−メントール、イソメントール、ピネン、カンフェン、リモネンなどの生理学的構成要素が、多様な皮膚活性化と皮膚健康に役立つと知られている。その他にも、ビタミンC、カロチン、フィトール(phytol)、ベタインなどが皮膚の疲労を解消して、元気で輝かしい皮膚を保持するのに役立つ。 Mint (scientific name: Mentha piperita) is a perennial plant belonging to the family Lamiaceae, and has been used for food and medicine for a long time in both the East and West. It is known that it has various effects useful for skin health as well as various pharmacological actions. The essential oil content in the main component of mint was 2% to 3%, 4% to 6% for petals, and 0.3% for stems. 70% to 90% of the main component of such mint essential oil is menthol, and physiological components such as I-menthol, isomenthol, pinene, camphene and limonene are useful for various skin activation and skin health. It is known. In addition, vitamin C, carotene, phytol, betaine, etc. help to relieve skin fatigue and maintain healthy and brilliant skin.
本発明の一実施形態において、前記ミントビネガーは、ミントを酢酸発酵したものである。酢酸発酵は、酢酸菌の作用によりアルコールが酸化され、酢酸を生成する好気性発酵であり、酢酸菌(Acetobacter aceti)はエタノールを酸化して、酢酸を生成する。酢酸発酵は、約12時間〜48時間の対数期を有してもよく、酸生成量は12〜24時間に急激に増加した。酢酸発酵において、酢酸生成能及び糖分解能は、培養温度30℃、エタノール4%添加された培地、pH6.5〜7で最も安定していた。 In one embodiment of the present invention, the mint vinegar is obtained by subjecting mint to acetic acid fermentation. Acetic acid fermentation is an aerobic fermentation in which alcohol is oxidized by the action of acetic acid bacteria to produce acetic acid. Acetobacter aceti oxidizes ethanol to produce acetic acid. Acetic acid fermentation may have a log phase of about 12 hours to 48 hours, with acid production increasing rapidly from 12 to 24 hours. In acetic acid fermentation, acetic acid producing ability and sugar resolving power were most stable in a culture temperature of 30 ° C., a medium supplemented with 4% ethanol, pH 6.5-7.
酢は、酢酸、クエン酸、アミノ酸、コハク酸などの約60種以上の有機酸を含み、ビタミンや無機質など各種栄養素の体内吸収を助ける促進剤の役割を果たす。特に、私たちの肉と血を浄化する血液浄化剤として作用し、人体の新陳代謝を促進して自然治癒力を最高レベルに高める効果があり、シミやソバカスを抑制し、皮膚老化の主因である過酸化脂質を抑制して、細胞の新陳代謝の活発に役立つ。さらに、皮膚と筋肉の乳酸を分解して、血液の流れがスムーズになるよう作用する。 Vinegar contains about 60 or more organic acids such as acetic acid, citric acid, amino acids, and succinic acid, and serves as a promoter that helps the body absorb various nutrients such as vitamins and minerals. In particular, it acts as a blood purification agent that purifies our meat and blood, promotes the metabolism of the human body and raises the natural healing power to the highest level, suppresses spots and freckles, and is the main cause of skin aging Inhibits lipid peroxides and helps to activate cell metabolism. In addition, it breaks down the lactic acid in the skin and muscles and acts to smooth the blood flow.
酢酸は、他の有機酸に比べて血液浄化、抗菌、老化防止、新陳代謝促進能力に優れる。 Acetic acid is superior to other organic acids in blood purification, antibacterial properties, anti-aging, and metabolism promoting ability.
本発明の一実施形態において、前記ミントビネガーは、液体の表面から微生物を繁殖させる培養法で製造されたものである。 In one embodiment of the present invention, the mint vinegar is produced by a culture method in which microorganisms are propagated from the surface of a liquid.
前記培養法で製造されたミントビネガーは、微生物の膜が常に空気と接触しており、液体表面から溶解した溶存酸素をうまく利用できる特徴を有し、既存のミントが持っている成分による効能だけでなく、酢酸発酵を通じて得ることができる長所も有している。 Mint vinegar produced by the above-mentioned culture method is characterized by the fact that the microbial membrane is always in contact with air, and that dissolved oxygen dissolved from the liquid surface can be used well, and only the effects of the components of existing mint are present. In addition, it has the advantage that it can be obtained through acetic acid fermentation.
本発明の一実施形態において、前記ミントは、ミントの葉及び茎のいずれか、又はこれらの組み合わせの抽出物である。 In one embodiment of the present invention, the mint is an extract of any of mint leaves and stems, or a combination thereof.
ミントの葉と茎は、殺菌、駆虫効果に優れ、口臭を防止し、歯磨き粉として使われる。葉を擦り砕いて湿布剤として使えば、皮膚の炎症、打撲傷治療に効果があり、皮膚炎、掻痒症の治療にも良い。大きな又は小さな傷から刺激された皮膚を鎮静させる一方、掻痒感及び異常反応を低減し、皮膚に活力とストレス解消を与え、軽い収斂作用及び弾性維持に役立つ。ミントの葉には、2%〜3%の精油を含有しており、ミントの茎には1%以内の精油を含有している。精油の約70%を占めているメントールは、ミント特有の香りと薬効を出す成分である。ミント固有の香りは、メントールとメントンから得ることができる。メントールの場合、収斂する性質があり、垂れた皮膚を引っ張り、毛穴を収縮させる効果があり、皮膚に良い効能を与える。また、皮膚の粘膜と血管を収縮して局所部位に清涼感を与える。独特の爽快感のある香りがするメントールは、無色の針状結晶であり、水にはほとんど溶けないが、エタノール、クロロホルムにはよく溶ける。ミントの葉や茎から得ており、多量を口中に入れれば、舌を刺すような感じがあるが、少量のときには清涼感が出る。 Mint leaves and stems have excellent bactericidal and anthelmintic effects, prevent bad breath and are used as toothpaste. If the leaves are crushed and used as a poultice, it is effective in treating skin irritation and bruises, and also in treating dermatitis and pruritus. While calming the stimulated skin from large or small wounds, it reduces itching and abnormal reactions, gives the skin vitality and stress relief, helps with light astringency and elasticity maintenance. Mint leaves contain 2% to 3% essential oil, and mint stems contain up to 1% essential oil. Menthol, which accounts for about 70% of the essential oil, is a component that produces a scent and medicinal properties peculiar to mint. Mint's unique aroma can be obtained from menthol and mentone. In the case of menthol, it has the property of converging, has the effect of pulling the dripping skin and shrinking the pores, and gives the skin a good effect. In addition, the mucous membranes and blood vessels of the skin contract to give a refreshing feeling to the local site. Menthol, which has a unique refreshing scent, is a colorless needle-like crystal that is almost insoluble in water, but well soluble in ethanol and chloroform. It is obtained from mint leaves and stems. If a large amount is put in the mouth, it feels like a stabbed tongue, but a small amount gives a refreshing feeling.
本発明の一実施形態において、前記化粧料組成物は、アルファヒドロキシ酸(AHA:α-Hydroxy Acid)を含有する。アルファヒドロキシ酸は、カルボン酸のα−位にある炭素に、アルコール基又はヒドロキシ基を添加した化合物であり、ケラチノサイトのイオン結合エネルギーを低くし、過剰なケラチノサイトを除去するか、新しい細胞の形成を促進して、皮膚が老化して垂れる角化過程の周期を短くし、皮膚細胞の活性を促進して、皮膚を改善する。また、繊維芽細胞(Fibroblast)によるコラーゲンとエラスチンの生成を促進して、皮膚を弾性及び軟質にし、真皮の重要な細胞外マトリックス成分であるムコ多糖(Mucopolysaccharide)の生成を促進して、皮膚保湿を増進させる。 In one embodiment of the present invention, the cosmetic composition contains alpha-hydroxy acid (AHA). Alpha hydroxy acid is a compound in which an alcohol group or hydroxy group is added to the carbon at the α-position of carboxylic acid, and lowers the ion binding energy of keratinocytes to remove excess keratinocytes or form new cells. Promotes and shortens the cycle of the keratinization process where the skin ages and droops, promotes the activity of skin cells and improves the skin. It also promotes the production of collagen and elastin by fibroblasts, making the skin elastic and soft, and promotes the production of mucopolysaccharide, an important extracellular matrix component of the dermis, to moisturize the skin. To improve.
本発明の一実施形態において、前記ミントビネガーの含量は、前記化粧料組成物全重量に対して、0.001重量%〜20重量%である。前記ミントビネガーが、0.001重量%未満のとき、本発明が目的とする十分な効果を期待することができなく、20重量%を超えると、ミントビネガーに含まれたメントール成分によって一時的な刺激感が現われることがある。 In one embodiment of the present invention, the content of the mint vinegar is 0.001% by weight to 20% by weight with respect to the total weight of the cosmetic composition. When the mint vinegar is less than 0.001% by weight, the sufficient effect intended by the present invention cannot be expected. When the mint vinegar exceeds 20% by weight, the menthol component contained in the mint vinegar temporarily A feeling of irritation may appear.
本発明の一実施形態において、前記化粧料組成物は、毛穴縮小用である。ミントが酢酸発酵されたミントビネガーは、収斂作用に優れたミントの効能が極大化され、毛穴が広くなることを予防し、垂れた毛穴の弾性を復活させる収縮効果がある。 In one embodiment of the present invention, the cosmetic composition is for pore reduction. Mint vinegar fermented with mint in acetic acid has a constrictive effect that maximizes the astringent effect of mint, prevents the pores from becoming wider, and restores the elasticity of dripping pores.
本発明の一実施形態において、前記化粧料組成物は、皮脂調節用である。ミントが酢酸発酵されたミントビネガーは、皮膚の血液浄化、抗菌、老化防止、新陳代謝を促進する効果があると同時に、老廃物を除去するだけでなく、毛穴の管理も可能にする。 In one embodiment of the present invention, the cosmetic composition is for sebum regulation. Mint vinegar fermented with mint in acetic acid has the effect of promoting skin blood purification, antibacterial activity, anti-aging, and metabolism, and at the same time not only removes waste products but also enables management of pores.
本発明による化粧料組成物は、その剤形において特に限定されず、例えば、柔軟化粧水、栄養化粧水、エッセンス、マッサージクリーム、栄養クリーム、パック、ゲル又は皮膚粘着タイプの化粧料に剤形化することができる。 The cosmetic composition according to the present invention is not particularly limited in its dosage form. For example, it is formulated into a soft lotion, nutritional lotion, essence, massage cream, nutritional cream, pack, gel, or skin adhesive type cosmetic. can do.
以下、試験例及び剤形例を参照して、本発明の構成及び効果をより具体的に説明する。しかし、これら試験例及び剤形例は、例示の目的のために提供され、本発明の範囲を限定するものではないことが理解されるだろう。 Hereinafter, with reference to a test example and a dosage form example, the structure and effect of this invention are demonstrated more concretely. However, it will be understood that these test examples and dosage form examples are provided for purposes of illustration and are not intended to limit the scope of the invention.
<製造例>
酢酸菌(Merck社製、菌株名:Acetobacter aceti KCTC1010)2〜3gを培地(マンニトール寒天培地/YPM/Medium)に、予め準備したミント材料100g(ミント葉75〜80重量%、茎20〜25重量%)を添加して接種した後、48時間、約26℃の温度で発酵した後、得られた発酵物に抽出溶液(精製水20mLとエタノール50mLとの混合液)を添加し、室温(25℃)で1時間抽出した。1次ろ過〔限外ろ過(細孔径=50μm)〕でエタノール及び材料を除去した後、純粋な発酵上清のみを取った。上清を再び遠心分離(超高速遠心分離機、400rpm)と2次ろ過〔限外ろ過(細孔径=10μm)〕を行った後、得られたろ液に、滅菌溶液100mL〔溶液全体積を基準に精製水70%〜94%、ブチレングリコール5%〜10%、ジナトリウムEDTA0.01%〜0.05%及び防腐剤(フェノキシエタノール)0.4%〜1.0%〕を混合し、120℃で10〜15分間の滅菌工程を経て、最終的にミントビネガー100mLを製造した。
<Production example>
2 to 3 g of acetic acid bacteria (manufactured by Merck, strain name: Acetobacter acetic KCTC1010) in a medium (mannitol agar medium / YPM / Medium), 100 g of mint material prepared in advance (75 to 80% by weight of mint leaves, 20 to 25% by weight of stems) %) Was added and inoculated, and after 48 hours of fermentation at a temperature of about 26 ° C., an extraction solution (mixed solution of 20 mL of purified water and 50 mL of ethanol) was added to the obtained fermented product, and room temperature (25 For 1 hour. After removing ethanol and materials by primary filtration [ultrafiltration (pore size = 50 μm)], only pure fermentation supernatant was taken. The supernatant was centrifuged again (ultra-high speed centrifuge, 400 rpm) and subjected to secondary filtration [ultrafiltration (pore size = 10 μm)], and then 100 mL of a sterilized solution [based on the total volume of the solution] 70% to 94% purified water, 5% to 10% butylene glycol, 0.01% to 0.05% disodium EDTA and 0.4% to 1.0% preservative (phenoxyethanol)] After 10 to 15 minutes of sterilization step, 100 ml of mint vinegar was finally produced.
一方、ミントビネガーの効能と対比するために、ミント抽出物を製造した。この抽出物は、ミント材料100g(ミント葉75〜80重量%、茎20〜25重量%)に抽出溶液100mL(溶液全体積を基準に精製水70%〜95%、ブチレングリコール5%〜30%)を添加し、室温で抽出して、ミント抽出物100mLを製造した。 On the other hand, a mint extract was prepared to contrast the efficacy of mint vinegar. This extract consists of 100 g of mint material (75 to 80% by weight of mint leaf, 20 to 25% by weight of stem) and 100 mL of extraction solution (70% to 95% purified water based on the total volume of the solution, 5% to 30% butylene glycol) ) And extracted at room temperature to produce 100 mL of mint extract.
<実施例及び比較例>
有効成分としてミントビネガーを含有する化粧料組成物として、下記の表1の組成を有する剤形例1の化粧料組成物を下記の方法で製造した。また、本発明の範囲内の剤形例1と比較するために、有効成分としてミント抽出物を含有する化粧料組成物として、下記の表1の組成を有する比較剤形例1の化粧料組成物を下記の方法で製造した。(単位:重量%)
<Examples and Comparative Examples>
As a cosmetic composition containing mint vinegar as an active ingredient, a cosmetic composition of Formulation Example 1 having the composition shown in Table 1 below was produced by the following method. Moreover, in order to compare with the dosage form example 1 within the scope of the present invention, the cosmetic composition of the comparative dosage form example 1 having the composition of Table 1 below as a cosmetic composition containing a mint extract as an active ingredient. The product was prepared by the following method. (Unit:% by weight)
室温で透明に溶解された水相に可溶化相を添加し、均一に溶解した後、ミントビネガーを投入し、均一に溶解して、剤形例1の化粧料組成物を製造した。また、比較剤形例1は、室温で透明に溶解された水相に可溶化相を添加し、均一に溶解した後、ミントビネガーを投入することなく、ミント抽出物を投入して、製造した。比較剤形例2は、室温で透明に溶解された水相に可溶化相を添加し、均一に溶解した後、ミントビネガーとミント抽出物をそれぞれ投入することなく、製造した。 The solubilized phase was added to the aqueous phase that was transparently dissolved at room temperature, and after uniformly dissolving, mint vinegar was added and dissolved uniformly to produce the cosmetic composition of Formulation Example 1. In addition, Comparative Dosage Form Example 1 was prepared by adding a solubilized phase to an aqueous phase that was transparently dissolved at room temperature, and uniformly dissolving the mint extract without adding mint vinegar. . Comparative dosage form example 2 was prepared without adding the mint vinegar and mint extract after adding the solubilized phase to the aqueous phase transparently dissolved at room temperature and dissolving it uniformly.
<試験例1>皮膚毛穴及び皮脂改善効能の評価
前記剤形例1、比較剤形例1及び比較剤形例2の皮膚弾性回復効果、毛穴縮小効果及び皮脂調節効果を確認するために、20代〜30代女性を対象に測定した。各群に剤形例1、比較剤形例1及び比較剤形例2の各剤形を顔面全体に均一に塗布した後、毛穴縮小効果及び皮脂調節効能を評価した。
<Test Example 1> Evaluation of skin pore and sebum improvement efficacy In order to confirm the skin elasticity recovery effect, pore reduction effect and sebum regulation effect of the above-mentioned formulation example 1, comparative formulation example 1 and comparative formulation example 2, Measurements were made on women in their teens to thirties. After each dosage form of Dosage Form Example 1, Comparative Dosage Form Example 1 and Comparative Dosage Form Example 2 was uniformly applied to the entire face in each group, the pore reduction effect and sebum regulating effect were evaluated.
本試験は、試験目的に適した被験者を対象に、恒温恒湿条件で当該試験製品を1回使うようにした。毛穴に悩みのある女性被験者を対象とし、一般的な使用方法で試料を使用して、試料の使用直後の毛穴管理効能を評価した。 In this test, the test product was used once under constant temperature and humidity conditions for subjects suitable for the test purpose. A female subject who suffers from pores was used as a target, and the sample was used in a general usage method, and the pore management efficacy immediately after use of the sample was evaluated.
洗顔後、試料の適当量(2mg/cm2)をとり、顔全体に手で優しくこすりながらまんべんなく塗布した。試験期間中の被験者は、一度の試料使用前と使用直後に評価を行った。被験者は、測定時点に訪問して、洗顔直後、恒温恒湿条件(22±2℃、40±5RH%)で15分間以上安静にした後、下記の表2に示される測定時点での試料使用及び評価を実施した。 After washing the face, an appropriate amount (2 mg / cm 2 ) of the sample was taken and applied evenly while gently rubbing the entire face by hand. Subjects during the test period were evaluated before and immediately after using the sample. The subject visited the measurement time point, and immediately after washing the face, kept at a constant temperature and humidity condition (22 ± 2 ° C., 40 ± 5RH%) for 15 minutes or more, and then used the sample at the measurement time point shown in Table 2 below. And the evaluation was carried out.
本試験例の試料の皮膚適用時の毛穴の大きさ、皮脂の大きさ及び個数の測定は、(株)アモーレパシフィック社が開発した測定装備スキンタッチを利用して評価した。スキンタッチは、一体型センサーによって皮膚の油分、水分、弾性の測定を行い、測定された結果は、外部のLCD表示窓に表示される。試料使用前、試料使用1週、2週経過後、スキンタッチを利用して試験部位を測定することによって、試料の皮膚適用時の毛穴の大きさ、皮脂の大きさ及び個数を評価した。 Measurements of pore size, sebum size and number of skin samples applied to the skin of this test example were performed using a measuring equipment skin touch developed by Amore Pacific Co., Ltd. Skin touch measures skin oil, moisture, and elasticity with an integrated sensor, and the measurement results are displayed on an external LCD display window. The size of pores and the size and number of sebum at the time of skin application of the sample were evaluated by measuring the test site using the skin touch before use of the sample and after 1 week and 2 weeks of use of the sample.
その結果、顔面毛穴部位の場合、有効成分としてミントビネガーを含有した試料を使用前に比べて、使用直後は、皮脂の数、皮脂の大きさ(単位:A.U.)、毛穴の大きさ(単位:A.U.)が下記表3に示されるように統計的に有意に減少した結果が明らかになった。 As a result, in the case of facial pores, the number of sebum, the size of sebum (unit: AU), and the size of the pores immediately after use compared to the sample containing mint vinegar as an active ingredient before use. As shown in Table 3 below, the result of statistically significant decrease in (unit: AU) was revealed.
前記表3と図1〜12の結果から、毛穴縮小及び皮脂調節効果を与える剤形例1の毛穴収縮、皮脂個数の減少及び毛穴個数の改善効果が比較剤形例1、比較剤形例2に比して、優れていることを確認することができた。 From the results shown in Table 3 and FIGS. 1 to 12, the results of Comparative Example 1 and Comparative Example 2 show that the pore shrinkage, the reduction in the number of sebum, and the improvement in the number of pores are as follows. It was confirmed that it was superior to
Claims (8)
The cosmetic composition according to claim 1, wherein the cosmetic composition is for sebum control.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020034079A JP6894991B2 (en) | 2014-04-24 | 2020-02-28 | Cosmetic composition containing mint vinegar as an active ingredient |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2014-0049216 | 2014-04-24 | ||
KR1020140049216A KR102249700B1 (en) | 2014-04-24 | 2014-04-24 | Comsmetic composition comprising mint vinegar |
PCT/KR2015/002965 WO2015163589A1 (en) | 2014-04-24 | 2015-03-26 | Cosmetic composition containing mentha haplocalyx as active ingredient |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020034079A Division JP6894991B2 (en) | 2014-04-24 | 2020-02-28 | Cosmetic composition containing mint vinegar as an active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2017513876A true JP2017513876A (en) | 2017-06-01 |
Family
ID=54332714
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016563931A Pending JP2017513876A (en) | 2014-04-24 | 2015-03-26 | Cosmetic composition containing mint vinegar as an active ingredient |
JP2020034079A Active JP6894991B2 (en) | 2014-04-24 | 2020-02-28 | Cosmetic composition containing mint vinegar as an active ingredient |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020034079A Active JP6894991B2 (en) | 2014-04-24 | 2020-02-28 | Cosmetic composition containing mint vinegar as an active ingredient |
Country Status (5)
Country | Link |
---|---|
JP (2) | JP2017513876A (en) |
KR (1) | KR102249700B1 (en) |
CN (1) | CN106232101B (en) |
SG (1) | SG11201608845PA (en) |
WO (1) | WO2015163589A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020525491A (en) * | 2017-06-30 | 2020-08-27 | アモーレパシフィック コーポレーションAmorepacific Corporation | Composition for skin cell damage care by dust containing Mentha albensis extract, skin barrier enhancement, and anti-aging or anti-inflammatory composition |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102212627B1 (en) * | 2017-06-30 | 2021-02-08 | (주)아모레퍼시픽 | Composition comprising Mentha Arvensis Extract for caring damages of skin cells by microdust |
KR102212626B1 (en) * | 2017-06-30 | 2021-02-08 | (주)아모레퍼시픽 | Composition comprising Mentha Arvensis Extract for Enhancing Skin Barrier |
KR102212625B1 (en) * | 2017-06-30 | 2021-02-08 | (주)아모레퍼시픽 | Composition comprising Mentha Arvensis Extract for anti-aging or anti-inflammation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63287716A (en) * | 1987-05-18 | 1988-11-24 | Hideko Nezu | Bathing agent |
IT1206794B (en) * | 1987-06-30 | 1989-05-03 | Iris Di Salvioli Michele E C S | PHYTOPREPARED FOR THE TREATMENT OF SKIN DISEASES. |
JP2001233726A (en) * | 2000-02-25 | 2001-08-28 | Kanebo Ltd | Cosmetic product and method for preventing natural colorant from fading |
CN100551348C (en) * | 2002-02-28 | 2009-10-21 | 日本克非尔株式会社 | Composition for external application |
CN101756855A (en) * | 2008-10-27 | 2010-06-30 | 吉祥 | Garlic toner |
KR101081913B1 (en) * | 2009-02-02 | 2011-11-09 | 한불화장품주식회사 | Skin agent composition containing the oriental-herb extracts using microbial fermentation |
KR101273066B1 (en) | 2009-10-30 | 2013-06-10 | (주)아모레퍼시픽 | Composition for Reducing Skin Pore Size or Secreting Sebum Containing flower extract of Potentilla chinensis |
KR101280481B1 (en) * | 2010-05-31 | 2013-07-01 | (주)내츄럴코리아 | Cosmetic for Improving Skin Wrinkle Comprising polyphosphate of fermented peppermint. |
KR101163069B1 (en) * | 2010-07-23 | 2012-07-04 | 함일한 | Cosmetic composition for anti-blemish and anti-wrinkle and method for manufacturing thereof |
KR101322850B1 (en) * | 2011-08-09 | 2013-10-28 | 이상록 | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum |
CN102370722B (en) * | 2011-10-02 | 2012-08-29 | 莫寿科 | External-application medicine for promoting venation dredging and beautifying face and body and preparation method thereof |
WO2013102234A1 (en) * | 2012-01-06 | 2013-07-11 | Ubs Ultimate Relief Pty Ltd | Formulation and method for treatment of pain and/or inflammation associated with a skin condition |
KR101370990B1 (en) * | 2012-03-08 | 2014-03-25 | 주식회사 유로코스텍 | Anti-heat aging effect of fermented Limonia acidissima extract and its cosmetic usage to improve skin problems |
KR20140115797A (en) * | 2013-03-22 | 2014-10-01 | 주식회사 이숨 | Cosmetic composition including the oriental medicine mixed extract and fermentation by-product removing hair sebum |
-
2014
- 2014-04-24 KR KR1020140049216A patent/KR102249700B1/en active IP Right Grant
-
2015
- 2015-03-26 SG SG11201608845PA patent/SG11201608845PA/en unknown
- 2015-03-26 CN CN201580021097.7A patent/CN106232101B/en active Active
- 2015-03-26 JP JP2016563931A patent/JP2017513876A/en active Pending
- 2015-03-26 WO PCT/KR2015/002965 patent/WO2015163589A1/en active Application Filing
-
2020
- 2020-02-28 JP JP2020034079A patent/JP6894991B2/en active Active
Non-Patent Citations (1)
Title |
---|
山田巳喜男: "酢酸発酵から生まれる食酢", 日本醸造協会誌, vol. 第102巻、第2号, JPN6019003762, 2007, pages 第115−120頁 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020525491A (en) * | 2017-06-30 | 2020-08-27 | アモーレパシフィック コーポレーションAmorepacific Corporation | Composition for skin cell damage care by dust containing Mentha albensis extract, skin barrier enhancement, and anti-aging or anti-inflammatory composition |
JP7158426B2 (en) | 2017-06-30 | 2022-10-21 | アモーレパシフィック コーポレーション | An anti-aging or anti-inflammatory composition for care of skin cell damage caused by fine dust, for strengthening skin barrier and anti-aging or anti-inflammatory composition containing Mentha arvensis extract |
Also Published As
Publication number | Publication date |
---|---|
SG11201608845PA (en) | 2016-11-29 |
KR20150122983A (en) | 2015-11-03 |
JP6894991B2 (en) | 2021-06-30 |
KR102249700B1 (en) | 2021-05-10 |
CN106232101A (en) | 2016-12-14 |
WO2015163589A1 (en) | 2015-10-29 |
CN106232101B (en) | 2020-02-28 |
JP2020100663A (en) | 2020-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6894991B2 (en) | Cosmetic composition containing mint vinegar as an active ingredient | |
KR101242736B1 (en) | Natural shampoo by using of ripen and decocted oriental medicine with the function of hair loss prevention and hair growth promotion and manufacturing method thereof | |
CN106137916A (en) | The cosmetic composition of a kind of removing acnes and controlling oil whitening and application thereof | |
CN113332162B (en) | protamine-PDRN compound, composition and application in preparation of skin care product | |
CN107714504A (en) | A kind of same human-like collagen composition and its applied in cosmetics | |
CN106176556A (en) | A kind of removing acnes and controlling oil whitening cream | |
CN108186394A (en) | Facial mask essence and preparation method are nourished in a kind of Shu Min maintenances | |
CN106265415A (en) | A kind of have moisturizing and the skin care compositions of after-sun restorative function and application thereof | |
CN108371642B (en) | Spring balance water and preparation method thereof | |
CN105796457B (en) | A kind of scar anti-acne print lotion and preparation method thereof of dispelling rich in natural extract | |
KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
KR102443283B1 (en) | Cosmetic composition with excellent skin barrier using skin microbiome | |
CN104248548A (en) | Plant extract-containing oxidation-resistant essence | |
CN103494737A (en) | Cosmetic preparation using ginger flower as anti-ageing and skin-protecting factor and preparation method of cosmetic preparation | |
CN108567862A (en) | Mite killing is releived compound borneol essential oil and preparation method thereof | |
CN115429738B (en) | Acne-removing, repairing and reviving essence and preparation method thereof | |
CN106727251A (en) | A kind of natural bee venom gel frost and its preparation technology | |
CN102872240A (en) | Compound essential oil for relaxing and activating collaterals | |
CN104546598A (en) | Preparation method of facial masks containing plant essential oil | |
KR20200074287A (en) | Composition for Improving Skin Condition or for Quasi-Drugs, Comprising Plant Extracts | |
KR102611907B1 (en) | The functional cosmetic composition containing Spicule Extract and a manufacturing method thereof | |
CN110882203A (en) | Compound high-permeability moisturizing essence and preparation process thereof | |
KR20090003828A (en) | Hair tonic containing composite for growig hair and preventing fall-out of hair | |
KR102233707B1 (en) | Cosmetic composition comprising natural extract and natural powder | |
CN104688636A (en) | Giant salamander anti-frost crack cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180111 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190513 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20191029 |